JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (1): 1-4.doi: 10.6040/j.issn.1671-7554.0.2016.1479

    Next Articles

Clinical concern of the second pregnancy under the two-child policy

CHEN Zijiang   

  1. Center for Reproductive Medicine, Shandong University;
    National Research Center for Assisted Reproductive Technology and Reproductive Genetics;
    Key Laboratory of Reproductive Endocrinology(Shandong University), Ministry of Education;
    Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan 250001, Shandong, China)
  • Received:2016-11-10 Online:2017-01-10 Published:2017-01-10

PDF (PC)

258

Abstract: The decree of two-child policy has brought more pressure and challenges for obstetrics and gynecology. Considering the declining fertility and health of elderly mothers, clinicians need to communicate sufficiently with them, assess carefully their fertility and physical status, and implement effective assisted reproductive measures. Moreover, it is necessary to establish a standardized pregnancy examination system for women with scarred uterus due to caesarean section. In addition, the newborns’ health condition should not be neglected. In conclusion, clinical management of second delivery will become a new focus, which needs concern and specification.

Key words: Two-child policy, Fertility in Advanced Age, Assisted reproductive technology

CLC Number: 

  • R711
[1] Cui Y, Shi Y, Cui L, et al. Age-specific serum antimullerian hormone levels in women with and without polycystic ovary syndrome[J]. Fertil Steril, 2014,102(1): 230-236.e2.
[2] Tietze C. Reproductive span and rate of conception among Hutterite women[J]. Fertil Steril, 1957, 8(1): 89-97.
[3] Cui L, Qin Y, Gao X, et al. Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause[J]. Fertil Steril, 2016, 105(2): 481-485.e1.
[4] Navot D, Bergh PA, Williams MA, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility[J]. Lancet, 1991, 337(8754): 1375-1377.
[5] Ganie MA, Marwaha RK, Dhingra A, et al. Observation of phenotypic variation among Indian women with polycystic ovary syndrome(PCOS)from Delhi and Srinagar[J]. Gynecol Endocrinol, 2016, 32(7): 566-570.
[6] Youssef MA, van Wely M, Al-Inany H, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial[J]. Hum Reprod, 2016, Epub 2016/11/12. doi: 10.1093/humrep/dew282.
[7] Wennberg AL, Opdahl S, Bergh C, et al. Effect of maternal age on maternal and neonatal outcomes after assisted reproductive technology[J]. Fertil Steril, 2016, 106(5): 1142-1149. e14.
[8] Rosato E, Perrone G, Capri O, et al. Hypertension and early menopause after the use of assisted reproductive technologies in women aged 43 years or older: Long-term follow-up study[J]. J Obstet Gynaecol Res, 2016, Epub 2016/10/09. doi: 10.1111/jog.13141.
[9] Ferraretti AP, Goossens V, de Mouzon J, et al. Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE[J]. Hum Reprod, 2012, 27(9): 2571-2584.
[10] Kupka MS, Ferraretti AP, de Mouzon J, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE[J]. Hum Reprod, 2014, 29(10): 2099-2113.
[11] Ferraretti AP, Goossens V, Kupka M, et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE[J]. Hum Reprod, 2013, 28(9): 2318-2331.
[12] Wu B, Shi J, Zhao W, et al. Understanding reproducibility of human IVF traits to predict next IVF cycle outcome[J]. J Assist Reprod Genet, 2014, 31(10): 1323-1330.
[13] Matorras R, Matorras F, Mendoza R, et al. The implantation of every embryo facilitates the chances of the remaining embryos to implant in an IVF programme: a mathematical model to predict pregnancy and multiple pregnancy rates[J]. Humreprod, 2005, 20(10): 2923-2931.
[14] Yang Y, Sun X, Cui L, et al. Younger poor ovarian response women achieved better pregnancy results in the first three IVF cycles[J]. Reprod Biomed Online, 2016, 32(5): 532-537.
[15] Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, et al. Pregnancy at very advanced maternal age: a UK population-based cohort study[J]. BJOG, 2016, 1. doi: 10.1111/1471-0528.14269.[Epub ahead of print]
[16] Lumbiganon P, Laopaiboon M, Gtllmezoglu AM, et al. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-2008[J]. Laneet, 2010, 375(9713): 490-499.
[17] Pirjani R, Seifmanesh F, Tehranian A, et al. Placental implantation and migration following a previous caesarean section scar[J]. Aust N Z J Obstet Gynaecol, 2016, Epub 2016/11/20. doi: 10.1111/ajo.12555.
[18] Yu L, Su CH, Wang XY, et al. Multi-centric clinical study of trial of labor after cesarean section[J]. Zhonghua Fu Chan Ke Za Zhi, 2016, 51(8): 581-585.
[19] Landon MB, Hauth JC, Leveno KJ, et al. Matemal and perinatal outcomes associated with a trial of labor after prior cesarean delivery[J]. N Eng J Med, 2004, 351(25): 2581-2589.
[20] 张进先. 瘢痕子宫再次妊娠分娩方式的选择及经阴道分娩安全性的临床分析[J]. 中国当代医药, 2015, 13(22): 113-115. ZHANG Jinxian. Clinical analysis on the selection of delivery mode for secondary pregnancy of cicatricial uterus and the safety of vaginal delivery[J]. China Modern Medicine, 2015, 13(22): 113-115.
[21] 金敏丽. 140例剖宫产后疤痕子宫再次妊娠分娩方式的临床分析[J]. 中华全科医学, 2014, 12(10): 1614-1616. JIN Minli. Clinical analysis of delivery method in 140 cases of cesarean scar pregnancy[J]. Chinese Journal of General Practice, 2014, 12(10): 1614-1616.
[22] Thomopoulos C, Tsioufis C, Michalopoulou H, et al. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review[J]. J Human Hypertens, 2013, 27(3): 148-157.
[23] Tatsumi T, Jwa SC, Kuwahara A, et al. No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology[J]. Hum Reprod, 2016. Epub 2016/11/09. doi: 10.1093/humrep/dew280.
[24] Bonne S, Sauleau E, Sananes N, et al. Influence of medically assisted reproduction techniques on crown-rump length and biochemical markers of trisomy 21 in the first trimester of pregnancy[J]. Fertil Steril, 2016, 105(2): 410-416.
[25] Davies MJ, Rumbold AR, Marino JL, et al. Maternal factors and the risk of birth defects after IVF and ICSI: a whole of population cohort study[J]. BJOG, 2016. Epub 2016/10/18. doi: 10.1111/1471-0528.14365.
[1] LI Mei. Quality of oocytes and embryos of elder women [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 16-21.
[2] DENG Xiaohui, XU Yaxuan. Fertility evaluation and assisted reproduction in elder women [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 5-10.
[3] YANG Dongzi, MAI Zhuoyao. Features of ovarian reserve and outcomes of assisted reproductive technology in elder patients with PCOS [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 26-32.
[4] SHI Yuhua, LI Jing. Strategies for infertility treatment in elderly women [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 22-25.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd